Hologic (Germany) Today

HO1 Stock  EUR 62.00  0.50  0.80%   

Performance

Weakest

 
Weak
 
Strong

Odds Of Distress

Tiny

 
High
 
Low
Hologic is trading at 62.00 as of the 2nd of February 2026. This is a 0.8 percent decrease since the beginning of the trading day. The stock's lowest day price was 62.0. Hologic has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 4th of November 2025 and ending today, the 2nd of February 2026. Click here to learn more.
Business Domain
Health Care Equipment & Services
Category
Healthcare
Classification
Health Care
Hologic, Inc., a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company was founded in 1985 and is headquartered in Marlborough, Massachusetts. The company has 223.24 M outstanding shares. More on Hologic

Moving against Hologic Stock

  0.574DS Daldrup Shne AktiengPairCorr
  0.51OEX Orezone GoldPairCorr
  0.412KT Konoike TransportPairCorr
  0.4LIN Linde plc Earnings Call This WeekPairCorr
  0.37BEI Beiersdorf AktiengesellschaPairCorr
  0.355VR VR Resources SplitPairCorr

Hologic Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Hologic's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Hologic or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Hologic's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Hologic's managers, analysts, and investors.
Environment Score
Governance Score
Social Score
President SolutionsJennifer Schneiders
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors)
Excise Tax ActivitiesAnimal Testing
Hologic's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Hologic's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Hologic utilizes debt financing to potentially enhance returns on invested capital. The relationship between total debt and total assets provides valuable insight into Hologic's leverage profile, showing how much of Hologic's resources are funded through borrowing.
Liquidity
Hologic cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Hologic has accumulated 2.9 M in total debt with debt to equity ratio (D/E) of 134.0, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Hologic has a current ratio of 1.64, which is within standard range for the sector. Debt can assist Hologic until it has trouble settling it off, either with new capital or with free cash flow. So, Hologic's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Hologic sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Hologic to invest in growth at high rates of return. When we think about Hologic's use of debt, we should always consider it together with cash and equity.

Investments

(5.58 Million)
Hologic (HO1) is traded on Frankfurt Exchange in Germany and employs 7,070 people. Hologic is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 14.25 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hologic's market, we take the total number of its shares issued and multiply it by Hologic's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Hologic classifies itself under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 223.24 M outstanding shares. Hologic has accumulated about 601.8 M in cash with 1.06 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.24.
Check Hologic Probability Of Bankruptcy
Ownership Allocation
Hologic has a total of 223.24 Million outstanding shares. The majority of Hologic outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Hologic to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Hologic. Please pay attention to any change in the institutional holdings of Hologic as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Hologic Ownership Details

Hologic Historical Income Statement

At this time, Hologic's Other Operating Expenses is most likely to decrease significantly in the upcoming years. The Hologic's current Non Recurring is estimated to increase to about 13.9 M, while Selling General Administrative is projected to decrease to roughly 959.9 M. View More Fundamentals

Hologic Stock Against Markets

Hologic Stock Analysis Notes

About 97.0% of the company shares are owned by institutional investors. The book value of Hologic was currently reported as 19.63. The company has Price/Earnings To Growth (PEG) ratio of 1.51. Hologic had not issued any dividends in recent years. Hologic, Inc., a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company was founded in 1985 and is headquartered in Marlborough, Massachusetts. HOLOGIC INC is traded on Frankfurt Stock Exchange in Germany. To learn more about Hologic call Stephen MacMillan at 508 263 2900 or check out https://www.hologic.com.

Hologic Quarterly Total Revenue

1.05 Billion

Hologic Investment Alerts

Hologic generated a negative expected return over the last 90 days
Hologic is unlikely to experience financial distress in the next 2 years
Hologic has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Over 97.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Zegona Communications Sets New 52-Week High - Should You Buy - MarketBeat

Hologic Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 14.25 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hologic's market, we take the total number of its shares issued and multiply it by Hologic's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Hologic Profitablity

Hologic's profitability indicators refer to fundamental financial ratios that showcase Hologic's ability to generate income relative to its revenue or operating costs. If, let's say, Hologic is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Hologic's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Hologic's profitability requires more research than a typical breakdown of Hologic's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.13 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.23 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.23.

Management Efficiency

Hologic has return on total asset (ROA) of 0.0743 % which means that it generated a profit of $0.0743 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1086 %, meaning that it generated $0.1086 on every $100 dollars invested by stockholders. Hologic's management efficiency ratios could be used to measure how well Hologic manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Hologic's Net Tangible Assets are most likely to increase significantly in the upcoming years. The Hologic's current Other Current Assets is estimated to increase to about 183.5 M, while Total Assets are projected to decrease to roughly 8.9 B.
Leadership effectiveness at Hologic is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin
0.2299
Profit Margin
0.1318
Beta
0.697
Return On Assets
0.0743
Return On Equity
0.1086

Technical Drivers

As of the 2nd of February, Hologic retains the Standard Deviation of 0.5872, risk adjusted performance of (0.03), and Market Risk Adjusted Performance of (0.37). Hologic technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Hologic information ratio, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk to decide if Hologic is priced fairly, providing market reflects its last-minute price of 62.0 per share.

Hologic Price Movement Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Hologic Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Hologic price patterns.

Hologic Outstanding Bonds

Hologic issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Hologic uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Hologic bonds can be classified according to their maturity, which is the date when Hologic has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Hologic Predictive Daily Indicators

Hologic intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Hologic stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Hologic Forecast Models

Hologic's time-series forecasting models are one of many Hologic's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Hologic's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Hologic without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Risk-Return Analysis Now

   

Risk-Return Analysis

View associations between returns expected from investment and the risk you assume
All  Next Launch Module

Hologic Corporate Management

Elected by the shareholders, the Hologic's board of directors comprises two types of representatives: Hologic inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hologic. The board's role is to monitor Hologic's management team and ensure that shareholders' interests are well served. Hologic's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hologic's outside directors are responsible for providing unbiased perspectives on the board's policies.
When determining whether Hologic offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hologic's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hologic Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hologic Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates.
For more detail on how to invest in Hologic Stock please use our How to Invest in Hologic guide.
You can also try the Stocks Directory module to find actively traded stocks across global markets.
Please note, there is a significant difference between Hologic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hologic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Hologic's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.